Inactive Instrument
Pressure BioSciences, Inc. Stock Other OTC
Stocks
PBIO
US74112E2081
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 143K 126K 117K 107K 202K 13.81M 205K 1.39M 543K 6.79M 538K 527K 23.47M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 20.16M 18.74M 17.2M 32.32M 2.21B 32.82M 223M 86.96M 1.09B 86.15M 84.29M 3.76B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 30.08K | |
| -0.57% | +6.61% | +19.50% | -0.67% | 213B | |
| -0.13% | -5.88% | -5.40% | -25.63% | 135B | |
| +1.94% | -2.22% | -30.87% | +4.39% | 117B | |
| +1.90% | +1.07% | -58.10% | -14.70% | 64.78B | |
| -0.32% | -2.60% | +10.16% | -8.64% | 48.26B | |
| +3.03% | -0.17% | -26.81% | -31.58% | 43.08B | |
| -0.69% | +5.64% | +15.40% | +8.74% | 39.47B | |
| -2.09% | +1.44% | +25.41% | +30.43% | 37.55B | |
| -1.21% | +4.76% | +81.65% | +3.97% | 29.78B | |
| Average | +0.11% | -3.37% | +3.44% | -3.74% | 80.91B | |
| Weighted average by Cap. | +0.21% | -4.90% | -0.88% | -5.80% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.52M 1.41M 1.3M 2.44M 167M 2.47M 16.77M 6.55M 81.88M 6.49M 6.35M 283M | 1.98M 1.74M 1.62M 1.48M 2.79M 190M 2.83M 19.18M 7.49M 93.64M 7.42M 7.26M 324M |
| Net income | -16.08M -14.12M -13.13M -12.05M -22.64M -1.55B -22.99M -156M -60.92M -761M -60.35M -59.05M -2.63B | -29.31M -25.75M -23.94M -21.97M -41.28M -2.82B -41.92M -284M -111M -1.39B -110M -108M -4.8B |
| Net Debt | 20.53M 18.03M 16.77M 15.38M 28.91M 1.98B 29.35M 199M 77.78M 972M 77.05M 75.39M 3.36B | 22.8M 20.03M 18.63M 17.09M 32.12M 2.2B 32.61M 221M 86.42M 1.08B 85.61M 83.76M 3.73B |
Employees
-
